AKT regulates androgen receptor-dependent growth and psa expression in prostate cancer

27Citations
Citations of this article
11Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Recurrent prostate cancer (PC) is usually treated with androgen deprivation therapy, which, despite initial success, eventually fails due to the development of androgen-independent PC. Androgen deprivation stimulates a significant increase in the phosphorylation (activation) of Akt, a serine/threonine kinase, which regulates cell growth and survival. Hence, we asked whether the increase in Akt phosphorylation contributes to the development of androgen independence. Akt regulates transcriptional activity of the androgen receptor (AR), and our data show that Akt-stimulated AR transcriptional activity is dependent on androgen-binding to the AR. PC proliferation has both androgen-sensitive and insensitive components. The androgen sensitive component is Akt-dependent, while the androgen-insensitive is not. However, Akt-induced cell survival is largely AR independent, suggesting that the cell stimulates Akt phosphorylation when subjected to androgen deprivation as an alternate pathway to maintain survival. © 2008 Springer Science+Business Media, LLC.

Cite

CITATION STYLE

APA

Mikhailova, M., Wang, Y., Bedolla, R., Lu, X. H., Kreisberg, J. I., & Ghosh, P. M. (2008). AKT regulates androgen receptor-dependent growth and psa expression in prostate cancer. In Advances in Experimental Medicine and Biology (Vol. 617, pp. 397–405). https://doi.org/10.1007/978-0-387-69080-3_38

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free